🔮 Other🌎 Remote💼 Full Time22d ago
Director, Value, Access & Pricing- US Rare Tumors (TGCT)
$167,000-$250,000/year
Sign in to unlock your personalized workspace. Upgrade and view full role details.
Role Details
About the company: the company, a healthcare company of Merck KGaA, Darmstadt, Germany, is a commercial-stage biopharmaceutical company dedicated to improving the lives of patients with rare tumors. We developed and…